LATEST PSYCHEDELICS STOCKS NEWS


Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031

Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031
725 views4 min read

Havn Life Sciences to Support the First Modern Psilocybin Depression Study in Germany With MIND Foundation

HAVN Life Sciences
The research will be led by Prof. Dr. Gerhard Gründer, the only confirmed scientist developing a study to work with psychedelics in Germany since the 1970sVANCOUVER, BC / ACCESSWIRE / October 30, 2020 / Havn Life Sciences Inc. (CNSX:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential... Read More...
393 views6 min read

Ghassan Halazon, EMERGE Founder & CEO, Named Recipient of Canada’s Top 40 Under 40®, Presented by BNN Bloomberg and National Post

Mind Cure Health
Mind Cure is accelerating its move into the mental health technology space with proprietary platformVANCOUVER, BC, Oct. 21, 2020 - Mind Cure Health Inc. (CSE: MCUR) ("Mind Cure" or the "Corporation") is pleased today to announce that it has entered into a non-binding letter of intent dated October 16, 2020 (the "LOI"), which sets out basi... Read More...
LOI1 views4 min read

IntelGenx Signs Letter of Intent with Heritage Cannabis for Long-Term Cannabis Filmstrip Supply Agreement

IntelGenx Technologies
SAINT LAURENT, Quebec, Oct. 29, 2020 -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has executed a binding letter of intent (“LOI”) with Heritage Cannabis Holdings Corp. (“Heritage”), an international medical cannabis licensed producer based in Toronto, Canada (CSE:CANN)(OTCQX:HERTF), for... Read More...
691 views7 min read

Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development

Results confirm that Field Trip's novel psychedelic molecule is similar in potency to psilocybin but with shorter duration of psychoactivity making it a potentially preferable option for psychedelic therapiesTORONTO, Oct. 29, 2020 -- Field Trip Health Ltd. (CSE: FTRP) (OTC: FTRPF) ("Field Trip"), the leader in the development and delivery... Read More...
148 views4 min read

Better Plant Receives Health Canada Approval for Plant-Based Antiseptic Skin Ointment

Better Plant Sciences
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") announces that it has received a Natural Health Product ("NHP") number (#80105697) from Health Canada for its plant-based, antimicrobial, antiseptic skin ointment. This pro... Read More...
M & A788 views8 min read

Organic Flower Acquires Ownership of 90 Percent of PowerTap Hydrogen Fueling

Clean Power Capital
VANCOUVER, British Columbia, Oct. 28, 2020 -- Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or the “Company” or "SOW") is pleased to announce that further to the Company’s news release on August 21, 2020 announcing its intention to augment its investment portfolio with a hydrogen sector investmen... Read More...
1 views3 min read

UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta

BetterLife Pharma
NEW YORK CITY, Oct. 28, 2020 -- UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon BetaThe Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing for clinical trials of AP-003, its interfer... Read More...
1 views3 min read

BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Other Treatements

BetterLife Pharma
New York City, Oct. 27, 2020 -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing for clinical trials of AP-003, its interferon alpha 2b COVID-19 treatment, joined investor portal Proactive to discuss the key differences between the interferon inhalation ... Read More...
1 views5 min read

Treasury Metals Announces Update on Preliminary Economic Assessment Study on Goliath and Goldlund Projects

New Wave Holdings
TSX: TML OTCQX: TSRMDTORONTO, Oct. 27, 2020 - Treasury Metals Inc. (TSX: TML) ("Treasury" or the "Company") is pleased to provide an update on the advancement of the Goliath Gold Project ("Goliath") and the Goldlund Gold Project ("Goldlund"), including progress on a NI 43-101 Preliminary Economic Assessment (the "PEA"). The Company has se... Read More...
747 views4 min read

NeonMind Manufactures 4 Superfood Mushroom Coffees

Better Plant Sciences
Vancouver, British Columbia--(Newsfile Corp. - October 27, 2020) -  Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") is pleased to announce that its majority owned subsidiary NeonMind Biosciences ("NeonMind") has completed an initial production run of all four of its Ayurvedic, functiona... Read More...
1644 views4 min read

Marianna Naturals Corp. Appoints Integral Transfer Agency as its Transfer Agent, and Secures Its CUSIP & ISIN

Primo Nutraceuticals
MONTREAL, Oct. 26, 2020 -- (MARIANNA NATURALS CORP.) is pleased to announce that it has retained the services of Integral Transfer Agency as its transfer agent and share registrar. The company signed the agreement with Integral on October 16th, 2020. This is an important move for the company in its final steps to list its common shares on... Read More...
381 views11 min read

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics
TORONTO, Oct. 26, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“U.S. FDA”) Phase 3 cl... Read More...
808 views3 min read

Havn Life Sciences Earns Health Canada Approval for Natural Health Product Formulations

HAVN Life Sciences
The initial six approved formulations were developed to enhance human performance and cognitive healthVANCOUVER, BC / ACCESSWIRE / October 26, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential using evidence-informed research and developing stan... Read More...
1 views4 min read

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO

COMPASS Pathways plc
COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPOLondon, UK – 26 October 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it will ring the Nasdaq Stoc... Read More...
1 views8 min read

Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals

Figure 1Actual GelMA-MN patch (10x close up)Actual GelMA-MN patch (10x close up)TORONTO, Oct. 22, 2020 -- Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pl... Read More...
1 views2 min read

Media advisory – Minister Ng to speak virtually to young entrepreneurs during Small Business Week

Numinus Wellness
OTTAWA, ON, Oct. 21, 2020 - The Honourable Mary Ng, Minister of Small Business, Export Promotion and International Trade, will join young entrepreneurs at the "Trailblazers: Mental Health and Entrepreneurship" online event hosted by Futurpreneur Canada, in partnership with BDC. The Minister will deliver opening remarks prior to panellists... Read More...
LOI393 views9 min read

Primo Nutraceuticals Inc. signs a Memorandum of Understanding for Exclusive Rights to Sell Rapid (Colloidal Gold Method) COVID-19 Test Kits in Canada

Primo Nutraceuticals
COVID-19 Test KitsCOVID-19 Test KitsCOVID-19 Test KitsVANCOUVER, British Columbia, Oct. 21, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (" PRIMO ") announces the signing of a Memorandum of Understanding (MOU) with Neo-Nostics ™ (Suzhou) Bioengineering Co. Ltd. Of Su Zhou City, Ch... Read More...
1 views4 min read

IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol

IntelGenx Technologies
SAINT LAURENT, Quebec, Oct. 21, 2020 -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into an amended and restated license agreement (the “Agreement”) granting Tetra Bio-Pharma (TSX:TBP)(OTCQB:TBPMF)(“Tetra”), a leader in cannabinoid-derived drug discovery and development, addit... Read More...
LOIM & A305 views6 min read

Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health

Mind Cure Health
Mind Cure is accelerating its move into the mental health technology space with proprietary platformVANCOUVER, BC, Oct. 21, 2020 - Mind Cure Health Inc. (CSE: MCUR) ("Mind Cure" or the "Corporation") is pleased today to announce that it has entered into a non-binding letter of intent dated October 16, 2020 (the "LOI"), which sets out basi... Read More...
M & A47 views8 min read

Empower Clinics Enters Canadian Market with Proposed Acquisition That Includes 6 Clinics and Incentives to Open Additional 30 Clinics and Announces Private Placement of Up to $1.1 Million

Empower Clinics
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESAcquisition Expands Company's North American Footprint And Strengthens Vertical Integration From Patients To LaboratoryVANCOUVER, BC / ACCESSWIRE / October 21, 2020 / Empower Clinics (CSE:CBDT)(OTC PINK:EPWCF)(FRA:8EC) (the "Company" or "Empow... Read More...
881 views6 min read

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

HAVN Life Sciences
Expanding research and development of naturally-derived psilocybin for future FDA IND-enabling and clinical studiesTORONTO, Oct. 20, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disor... Read More...
959 views4 min read

NeonMind Superfood Mushroom Coffee Update

Better Plant Sciences
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") is pleased to announce that its majority owned subsidiary NeonMind Biosciences ("NeonMind") has completed production of two out of four of its superfood mushroom coffee ble... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!